与SIN3A结合THOC1复合体,以调节R环并促进质母细胞瘤的进展
bioRxiv : the preprint server for biology
|October 10, 2024
概括
通过调节R循环,THO复合物1 (THOC1) 驱动着质母细胞瘤 (GBM) 的扩散. 抑制THOC1通过破坏端粒R循环平衡来降低GBM活力和瘤生长,提供了一个潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 质母细胞瘤 (GBM) 是一种具有不良预后的侵袭性脑瘤.
- 确定新的治疗点对于改善GBM患者的存活率至关重要.
研究的目的:
- 为了确定质母细胞瘤扩散的关键驱动因素.
- 调查THO复合物1 (THOC1) 在GBM病变发生过程中的作用.
- 探索THOC1作为GBM的潜在治疗点.
主要方法:
- 用CRISPR敲门选来识别GBM扩散的驱动因素.
- 在体外细胞活力测定使用患者衍生异种移植 (PDX) 线.
- 在体内瘤移植研究.
- RNA测序用于分析基因表达网络.
- 对R循环形成和基因组脱乙化水平的分析.
主要成果:
- 确定THO复合物1 (THOC1) 是GBM扩散的一个关键驱动因素.
- 在PDX模型中,THOC1倒置显著降低了GBM细胞活力,提高了PDX模型中的存活率.
- THOC1与SIN3A基因组脱乙酶复合体相互作用,影响R循环稳态.
- 降低THOC1导致R环水平增加,特别是在端粒,并导致端粒缩短.
- 过度表达THOC1促进了非癌细胞的活力和瘤移植.
结论:
- 通过调节R循环形成,THOC1在维持GBM细胞活力和增殖方面发挥着至关重要的作用.
- 准THOC1会破坏端粒R循环平衡,可能会破坏GBM的复制能力.
- 在质母细胞瘤治疗中,THOC1是一个有前途的治疗标.
更多相关视频
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
5.6K
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
6.8K
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Hedgehog Signaling Pathway
7.3K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.3K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
